2 completed, 2 recruiting, 1 active not recruiting. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 2, Recruiting 2, Active not recruiting 1 |
Follow Giant Cell Tumors: new trials by email Literature Review of Giant Cell Tumors trials Research Report on Giant Cell Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery Indocyanine Green - Giant Cell Tumor of Bone | Phase 4 | Recruiting | Shanghai Jiao Tong University Affiliated Sixth People's Hospital | 40 | 2026-01-02 | 2026-01-05 |
| Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Tenosynovial Giant Cell Tumor Surgery Indocyanine Green - Tenosynovial Giant Cell Tumor | Phase 4 | Recruiting | Shanghai Jiao Tong University Affiliated Sixth People's Hospital | 40 | 2026-01-02 | 2026-01-05 |
| Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone XGEVA® - Giant Cell Tumor of Bone | Phase 4 | Active not recruiting | Amgen | 36 | 2023-08-17 | 2025-10-01 |
| Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib Pexidartinib - Tenosynovial Giant Cell Tumor | Phase 4 | Completed | Daiichi Sankyo | 32 | 2020-10-20 | 2024-12-30 |
| Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004 Denosumab - Giant Cell Tumor of Bone | Phase 4 | Completed | Amgen | 85 | 2017-11-13 | 2024-05-20 |
Giant Cell Tumor of Bone (3) · Giant Cell Tumor of Tendon Sheath (2)
Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms, Connective Tissue (5) · Neoplasms, Connective and Soft Tissue (5) · Neoplasms, Bone Tissue (3) · Joint Diseases (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Synovitis (2) · Tendinopathy (2)
Denosumab (2) · Indocyanine Green (2) · pexidartinib (1)
Amgen (2) · Shanghai Jiao Tong University Affiliated Sixth People's Hospital (2) · Daiichi Sankyo (1)
China (3) · Australia (2) · Italy (2) · Spain (2) · Taiwan (2) · United States (2) · France (1) · Hungary (1) · Netherlands (1) · Poland (1) · Sweden (1) · United Kingdom (1)
PMID 21613624, PMID 31188797, PMID 32224746, PMID 37121591, PMID 37178368, PMID 17013643, PMID 28057477, PMID 29290809, PMID 33094400, PMID 33214476, PMID 33754215, PMID 35230489, PMID 35837703, PMID 36502615, PMID 37121582
2017 (1)